Archives

by in
Entry Author Date Location
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
San Diego Life Sciences Roundup: Halozyme, Acadia, Trovagene, & More 03/29/13 San Diego
In VC ‘Hat Trick’ for San Diego’s Avalon, RQx Inks Genentech Deal 02/12/13 San Diego
San Diego Life Sciences Roundup: Trius, CoDa, Zacharon, & More 01/11/13 San Diego
With New Antibiotic in Hand, RQx Pharmaceuticals Looks for Partner 11/28/12 San Diego
In Search of Meaningful GAIN in Renewal of Prescription Drug Act 07/11/12 San Diego
Cardeas Gears Up for Clinic, With Drug Combo for Hospital Infections 04/26/12 Seattle
Trius Antibiotic Passes Pivotal Study Against Pfizer’s Zyvox 12/19/11 San Diego
San Diego’s Trius Therapeutics Creates Options for the Next Generation of Antibiotics 05/25/11 San Diego
Optimer Inks Potential $47.5M-Plus Deal with Cubist to Help Sell Antibiotic 04/06/11 San Diego
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Intellectual Ventures’ Latest Big Push: Turning Med-Tech Inventions Into Cash 10/18/10 Seattle
Trius Ends First Day Trading at $5 a Share 08/03/10 San Diego
Trius Chops IPO Price, Offers More Shares 08/02/10 San Diego
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics 07/19/10 San Francisco
Trius IPO Plans Back on Track 07/15/10 San Diego
Cubist Maintains Growth Streak, As Investors Fear Generic Threat, Thin Pipeline 01/25/10 Boston
Cubist to Acquire Calixa Therapeutics in Deal Worth up to $402.5M 12/14/09 Boston
Good Things in Threes: Trius Therapeutics Files for IPO to Fund Phase 3 Clinical Trials, Marks San Diego’s Third IPO Filing 11/09/09 San Diego
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego 10/27/09 San Diego
Trius Approaches Next Stage in Drug Development, China Partnerships a Hot Topic at CalAsia, Lpath Headed to Critical Juncture, & More San Diego Life Sciences News 06/18/09 San Diego
Trius Looks to Cut a Deal, Gears Up For Final Stage of Trials with New Antibiotic 06/12/09 San Diego
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News 06/11/09 San Diego
Trius, Developer of Antibiotic for Deadly MRSA Bacteria, Passes Key Test 06/08/09 San Diego
Moving Fast, Trius Therapeutics Assesses Capital Needs for Late-Stage Clinical Trials 04/07/09 San Diego
Indel Therapeutics Aims High With New Class of Antibiotics to Fight Hospital Infections 03/30/09 Seattle
Vioguard CEO Larry Ranta Takes Germ-Zapping Keyboard Into Growing Hospital Market 03/26/09 Seattle
Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic 03/24/09 San Diego
Novophage Forming to Combat Antibiotic Resistance with Engineered Viruses 03/05/09 Boston
Teva Takes Aim at Cubist Pharma’s Key Antibiotic Business 02/10/09 Boston
Page 1 of 2 next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.